- Home
- VHI vs CRMD Comparison
VHI vs CRMD Comparison
Compare VHI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- CRMD
- Stock Information
- Founded
- VHI 1932
- CRMD 2006
- Country
- VHI United States
- CRMD United States
- Employees
- VHI N/A
- CRMD N/A
- Industry
- VHI Major Chemicals
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- CRMD Health Care
- Exchange
- VHI Nasdaq
- CRMD Nasdaq
- Market Cap
- VHI 447.6M
- CRMD 973.3M
- IPO Year
- VHI N/A
- CRMD 2010
- Fundamental
- Price
- VHI $18.10
- CRMD $11.62
- Analyst Decision
- VHI Sell
- CRMD Strong Buy
- Analyst Count
- VHI 1
- CRMD 7
- Target Price
- VHI $12.00
- CRMD $17.33
- AVG Volume (30 Days)
- VHI 25.1K
- CRMD 2.5M
- Earning Date
- VHI 08-07-2025
- CRMD 08-13-2025
- Dividend Yield
- VHI 1.77%
- CRMD N/A
- EPS Growth
- VHI 4465.30
- CRMD N/A
- EPS
- VHI 4.11
- CRMD 0.28
- Revenue
- VHI $2,112,800,000.00
- CRMD $82,553,827.00
- Revenue This Year
- VHI $22.20
- CRMD $238.38
- Revenue Next Year
- VHI $7.66
- CRMD $53.52
- P/E Ratio
- VHI $4.41
- CRMD $41.86
- Revenue Growth
- VHI 7.82
- CRMD N/A
- 52 Week Low
- VHI $14.10
- CRMD $3.61
- 52 Week High
- VHI $41.75
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- VHI 67.06
- CRMD 39.52
- Support Level
- VHI $15.95
- CRMD $12.14
- Resistance Level
- VHI $18.70
- CRMD $17.43
- Average True Range (ATR)
- VHI 0.77
- CRMD 0.69
- MACD
- VHI 0.28
- CRMD -0.51
- Stochastic Oscillator
- VHI 82.56
- CRMD 4.60
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.